Compounded · Dual GLP-1 / GIP receptor agonist

Compounded Tirzepatide

Tirzepatide activates both GLP-1 and GIP receptors, producing greater average weight loss than GLP-1 alone in clinical trials. Compounded versions contain the same active ingredient as Mounjaro® and Zepbound®.

Starting at$279 / 28-day supply
Compounded tirzepatide vials with discreet CNM branding
Form
Vial + syringe (subcutaneous injection)
Frequency
Once weekly
Drug class
Dual GLP-1 / GIP receptor agonist

Who is a candidate for this medication?

  • Adults 18+ with a BMI of 30+, or 27+ with a weight-related condition.
  • Have tried GLP-1 mono-therapy or want the highest average efficacy option.
  • No contraindications to GLP-1/GIP therapy.

Who this medication is not for

  • Personal or family history of medullary thyroid cancer or MEN 2.
  • Currently pregnant, trying to conceive, or breastfeeding.
  • History of pancreatitis or severe GI motility disorders.
  • Type 1 diabetes.

Dosage overview

PhaseDose
Weeks 1–42.5 mg once weekly.
Weeks 5–85 mg once weekly.
Weeks 9+Titrated up to 7.5–15 mg based on tolerance and goals.

Side effects to know about

Common

  • · Nausea
  • · Diarrhea or constipation
  • · Decreased appetite
  • · Vomiting
  • · Injection-site reactions

Serious (call your doctor)

  • · Pancreatitis
  • · Gallbladder disease
  • · Acute kidney injury
  • · Severe GI reactions

How your care is monitored

  • Physician check-in at weeks 4, 12, and quarterly.
  • Weight, blood pressure, side-effect and hydration review at each visit.
  • Metabolic labs reviewed as clinically indicated.

Pricing

Compounded Tirzepatide starts at $279 / 28-day supply. No insurance required. HSA/FSA eligible.

Prescription required. Our licensed provider determines whether treatment is medically appropriate. Medication and dose are not guaranteed. Prices shown apply to the stated supply period and may vary if the prescribed treatment, pharmacy, or product changes.

Common questions

Is tirzepatide more effective than semaglutide?

In head-to-head trials (SURMOUNT-1 vs STEP-1), tirzepatide 15 mg produced roughly 20–22% average body weight loss vs ~15% for semaglutide 2.4 mg. Individual results vary.

Why is tirzepatide priced higher?

It's a newer, more complex molecule and dual-target formulation.

Ready to see if Compounded Tirzepatide is right for you?

Complete a 5-minute online intake. A US-licensed physician reviews your history and only prescribes if it's safe and appropriate for you.

Check If I Qualify — Free & Fast